Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis.
about
Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published data.Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B.Drug resistance in visceral leishmaniasis.Drug delivery strategies for therapy of visceral leishmaniasis.Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives.Polymeric colloidal particulate systems: intelligent tools for intracellular targeting of antileishmanial cargos.Emulsomes meet S-layer proteins: an emerging targeted drug delivery system.Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasis.Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules.Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasis.Drug targeting to macrophages using paromomycin-loaded albumin microspheres for treatment of visceral leishmaniasis: an in vitro evaluation.Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery.Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy.Development and evaluation of tripalmitin emulsomes for the treatment of experimental visceral leishmaniasis.Preparation and performance evaluation of emulsomes as a drug delivery system for silybin.
P2860
Q33853860-0F255341-231B-4F78-A82E-92294032B09AQ37033956-F8C8387B-6173-49FF-A6DF-A2E94BD94DE8Q37407549-9560969B-049D-4712-9716-40DDB9DE7A67Q37702257-135AB265-6DD6-44B5-A8F2-04E6F6DEA761Q38154347-D9A29464-7DC8-4162-B363-59F5EB5C885BQ38154629-9D7B1002-8B38-4501-AE04-F351A39EE122Q38361935-6FC1CE64-9576-45E3-B96D-23E568127776Q39017657-8025D822-4035-4DB5-AB9B-3CD94C44EB3BQ39203200-E58EABC0-287C-4913-9B1B-D82224CFA641Q39547523-554C7582-3291-4977-8C77-1551A1633639Q39693592-97426479-FACB-4200-B2A1-D8E57F015AFBQ41879261-DD106C67-5770-497A-A7B5-242E1DB4DB7CQ43978694-B6738598-D788-47CF-B0E0-FC0CC3B54C8AQ51766744-59CC4176-5A39-4074-B153-EBCF4227E906Q53436548-0D18C99E-A0C0-436C-9E54-211F6276DBD2
P2860
Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Antileishmanial efficacy of am ...... mental visceral leishmaniasis.
@en
Antileishmanial efficacy of am ...... mental visceral leishmaniasis.
@nl
type
label
Antileishmanial efficacy of am ...... mental visceral leishmaniasis.
@en
Antileishmanial efficacy of am ...... mental visceral leishmaniasis.
@nl
prefLabel
Antileishmanial efficacy of am ...... mental visceral leishmaniasis.
@en
Antileishmanial efficacy of am ...... mental visceral leishmaniasis.
@nl
P2093
P2860
P1476
Antileishmanial efficacy of am ...... mental visceral leishmaniasis.
@en
P2093
Anuradha Dube
Suresh P Vyas
Swati Gupta
P2860
P304
P356
10.1080/10611860701453836
P577
2007-07-01T00:00:00Z